Medirune Co., Ltd. secured competitiveness through “portable period pain reliever” in home medical device market

WONJU--(Korea Newswire)--The home medical device market has been growing rapidly as there has been the increased interest for disease prevention due to the aging society and the increase of small family. It is possible to use conveniently through the simple operation anytime in anywhere without going to hospitals; thereby, saving time and money. And patients can care their health by themselves.

According to the research and analysis report on the home medical device market, which was conducted by the US market research institute, BBC research, predicts that the global home medical device market will grow to USD 29.8 billion with the average annual growth rate of 6.8 percent. And the size of the domestic market, researched by Korea Medical Devices Industrial Cooperative Association, is also expected to become KRW 1.687 trillion in 2020, which will be three times the current size.

In this market trend, the growth of Medirune Co., Ltd. (CEO Shin Won Kang, www.medirune.com), a Korean company specialized in medical device, draws attention. The company has been receiving positive responses as embarking on entering overseas markets in addition to the domestic market with the pain reliever products for home use since its inception in 2009.

It is supplying its products to numerous Internet shopping malls and public offices, schools (infirmary), municipal governments and health centers in Korea. And as for the overseas markets, the company operates the local branches in Indonesia and Vietnam, and it is exporting to the four countries in overseas including the US, India, Germany, Singapore, etc.

“We have recently acquired the certifications of INVIMA of Columbia, SFDA of China and CE of Europe, and we are about to acquire the certifications of overseas import permission from FDA of the US and QSD of Taiwan; thus, we plan to embark on entering overseas markets more aggressively from the time of those being completed.

“I-Rune” (model name: I-200L), which is the pain reliever product of Medirune Co., Ltd., is the product that is effective in relieving period pain of women. It helps to address the inconvenience of period pain conveniently at home, which had to be treated through medical treatment or drugs at hospitals. Moreover, men and women of all ages may use it easily since it is effective for general pains.

The body features the delicate and sensuous design that reminds of a general MP32, and it enhanced the portability with the compact size. Anyone can use it with the consumer-centric convenient GUI and the simple operation measure. And it can be charged through USB or a general 24pin adopter for mobile phone.

The main pad is the one to treat pain with the blood path as integrating warm heat and tens simultaneously; thus, it is developed based on the company’s credible technological capabilities of having acquired the domestic and overseas patents such as the US, China, Japan, etc., which are “the period pain reliever by blood path (No. 10-0899818)” and “the portable combined stimulator to relieve period pain (No. 10-0915320)”. The low frequency patch alleviates pain through generating beta-endorphin that does the analgesic effect by low irritation and low frequency, and it may be utilized to treat obesity or strengthen muscles in addition to relieving pain.

Recently, the company has also released the diffusion model “I-Rune Basic” based on such technological capabilities. It is composed of the two channels; thus, enabling users to use the four patches simultaneously, and it is equipped with the period pain relief mode (TENS) and the low frequency massage function.

“It is the portable pain reliever product to relieve period pain that is the most common pain disease for women, and it has been receiving good responses from both domestic and overseas markets as increasing the awareness among the consumers,” CEO Shin Won Kang said. “We will consistently try to contribute to the development of the domestic home medical device industry as well as the global market through the steady research and development.”

Meanwhile, Medirune Co., Ltd. has completed the development of the pain control application for smart phone “I-Rune Smart”, which is scheduled to be released in July next year. (Inquiries: +82-33-765-5739)

Website: http://www.medirune.com

This is a news release distributed by Korea Newswire on behalf of this company.